Congenital Portosystemic Shunt: Clinical Trials

2 trials for Congenital Portosystemic Shunt, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation, 1 not yet recruiting. .

Follow Congenital Portosystemic Shunt: new trials by email Literature Review of Congenital Portosystemic Shunt trials Research Report on Congenital Portosystemic Shunt

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Genetic Hallmarks of Patients With Congenital Portosystemic Shunts and Portopulmonary Hypertension
targeted gene panels analysis, whole genome analysis - Portopulmonary Hypertension, Pulmonary Arterial Hypertension (PAH)
Not yet recruitingProf. Valérie Mc Lin1202026-02-012026-01-20
International Registry of Congenital Portosystemic Shunt (IRCPSS)
Shunt Closure - Congenital Portosystemic Shunt, CPSS (Congenital Portosystemic Shunt)
Enrolling by invitationProf. Valérie Mc Lin5002018-04-262025-06-18

Narrower conditions

Hepatic Encephalopathy (1)  ·  Hepatopulmonary Syndrome (1)  ·  Hyperammonemia (1)  ·  Hyperandrogenism (1)  ·  Hyperinsulinism (1)  ·  Hypertension, Pulmonary (1)  ·  Hypoglycemia (1)  ·  Insulin Resistance (1)  ·  Liver Neoplasms (1)  ·  Pulmonary Arterial Hypertension (1)  ·  Rare Diseases (1)  ·  Vascular Malformations (1)

Broader conditions

Cardiovascular Abnormalities (2)  ·  Cardiovascular Diseases (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Lung Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  46, XX Disorders of Sex Development (1)  ·  Adrenogenital Syndrome (1)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Central Nervous System Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Disease Attributes (1)  ·  Disorders of Sex Development (1)

Interventions

Genome-Wide Association Study (1)

Sponsors

Prof. Valérie Mc Lin (2)

Countries

Switzerland (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  India (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

NIH funding

2018 (1)